MiracleCord

MiracleCord is a private U.S. cord blood and cord tissue banking company that collects, processes, and cryopreserves newborn umbilical cord blood and cord tissue for potential future medical use. The company markets its services directly to families and emphasizes rapid transport, laboratory processing, long-term storage, and quality assurance. Its laboratory is described as AABB accredited, CLIA certified, and FDA registered, and the company highlights cord blood and cord tissue preservation as a way to retain hematopoietic and mesenchymal stem cell potential for future therapies. MiracleCord appears to operate as a commercial healthcare services business rather than a drug-development biotech with a traditional therapeutic pipeline. The company is headquartered in Chicago, Illinois and is led by founder and CEO Mark Locascio.